Scott Fidel analyst STEPHENS

Currently out of the existing stock ratings of Scott Fidel, 137 are a HOLD (35.86%), 238 are a BUY (62.3%), 7 are a SELL (1.83%).

Scott Fidel

Work Performance Price Targets & Ratings Chart

Analyst Scott Fidel, currently employed at STEPHENS, has had 76.62% of price targets met with an average potential upside of 19.48%, reached in 244 days on average. Previously, Scott Fidel worked at CREDIT SUISSE, GOLDMAN SACHS, DEUTSCHE BANK.

Scott Fidel has documented 757 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on UHS, at 30-Jul-2026.

Wall Street Analyst Scott Fidel

Analyst best performing recommendations are on GRDN.
The best stock recommendation documented was for HUM on 10/9/2024. The price target of $250 was fulfilled within 2 days with a profit of $10.56 (4.41%), with a performance score of 22.05.

Average potential price target upside

AMED ANTM CI Cigna Corp CNC EHC HUM MGLN MOH PNTG UHS UNH ENSG HCA LHCG THC ADUS AVAH ELV MODV WCG ACHC CYH ALHC ARDT PACS AME AN AutoNation GRDN LH CVS

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Feb-2023

$100

$100

1 years 7 months 3 days ago
(16-Apr-2025)

3/4 (75%)

$8.09 (8.80%)

347

Hold Since 21-Apr-2023

$101

$101

1 years 7 months 15 days ago
(04-Apr-2025)

2/9 (22.22%)

$9.11 (9.91%)

419

Hold Since 26-Mar-2024

1 years 8 months 9 days ago
(10-Mar-2025)

6/11 (54.55%)

$12.13 (9.49%)

97

Hold Since 21-Oct-2019

$101

$91

1 years 8 months 15 days ago
(04-Mar-2025)

6/13 (46.15%)

$8.9 (9.66%)

25

Buy Since 03-Aug-2018

$100

$139

1 years 10 months 20 days ago
(30-Dec-2024)

8/14 (57.14%)

$9.51 (10.51%)

89

Show more analysts

Please expand the browser size to see the chart

Which stock is Scott Fidel most bullish on?

Potential upside of $26.65 has been obtained for CVS

Which stock is Scott Fidel most reserved on?

Potential downside of -$16.19 has been obtained for HCA

What Year was the first public recommendation made by Scott Fidel?

On 2008
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?